Comparison 38. Ayurvedic SGCG versus celecoxib.
Outcome or subgroup title | No. of studies | No. of participants | Statistical method | Effect size |
---|---|---|---|---|
1 Pain VAS 0‐100 change from baseline | 1 | 220 | Mean Difference (IV, Random, 95% CI) | ‐2.0 [‐7.42, 3.42] |
2 WOMAC 0‐4 (Function) change from baseline | 1 | 220 | Mean Difference (IV, Random, 95% CI) | 0.19 [‐2.59, 2.97] |
3 Participants (n) reported adverse events | 1 | 208 | Odds Ratio (M‐H, Random, 95% CI) | 0.82 [0.45, 1.48] |